ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, NATALEE, DESTINY-BREAST12, and CAPItello-290 | VuMedi

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, NATALEE, DESTINY-BREAST12, and CAPItello-290

By 2024 ESMO Annual Meeting Insights Hub FEATURING Virginia Kaklamani

By 2024 ESMO Annual Meeting Insights Hub FEATURING Virginia Kaklamani

478 views

September 23, 2024

KEYNOTE-522: Immunotherapy in Early-Stage TNBC

00:00

Adjuvant Endocrine Therapy Advances

02:45

DESTINY-BREAST12: HER2-Low Breast Cancer Treatment

04:20

CAPItello-290: AKT Pathway Targeting

06:49

Comments 0

Login to view comments. Click here to Login